NAMSA opens expanded preclinical lab near Minneapolis
2023-10-02
并购
North American Science Associates (NAMSA) recently opened its expanded preclinical lab near Minneapolis.
It is “the biggest worldwide preclinical facility dedicated to medical medtech services,” NAMSA CEO Christophe Berthoux said in a promotional video by Medical Alley.
The facility — at 8945 Evergreen Boulevard in Coon Rapids, Minnesota — now has six cath labs and three operating rooms. The company said it added one more of each in the expansion to reduce wait times for procedures.
“We can do all sorts of different development studies for medical device manufacturers, all the way from very basic interventional procedures such as stent placement to highly complex studies” such as extracorporeal membrane oxygenation (ECMO), NAMSA SVP of Global Laboratory Operations Lisa Olson said in the video.
Toledo, Ohio-based NAMSA also expanded the facility’s lobby, break room, and locker space.
NAMSA announced the expansion in November 2021, saying it would add 55,000 ft² to the campus, which totaled 130,000 ft² at the time. The medtech contract research organization said wait times were as long as nine months at competitors.
Berthoux became NAMSA’s CEO in March 2021 after his private equity firm, ArchiMed, took a majority stake in the organization in September 2020. Since then, NAMSA has completed at least eight acquisitions, including American Preclinical Service, Syntactx and — most recently — The Clinical Research Institute.
更多内容，请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。
适应症
-靶点
-药物
-来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。